Study Title: LCCC 2047: A Phase II Trial of Induction and Maintenance Pembrolizumab and Olaparib in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Kaczmar, John, at kaczmar@musc.edu, or please call +1 843-792-6691.Study Coordinator, Avinger, Madison, at avingerm@musc.edu.Trial opened at the following institutions: Medical University of South Carolina